My Size Inc stock (US62844N3030): Nasdaq micro-cap trades quietly ahead of next catalysts

My Size shares on Nasdaq in the United States traded in a narrow range on 05/29/2026, with modest volume and no new company press release or SEC filing published the same day, leaving the stock largely directionless as investors look beyond the last major update in March 2026 on the planned merger with Israeli e-commerce firm Orgad, according to Nasdaq data as of 05/29/2026 and recent company disclosures.

The stock is listed on Nasdaq under the ticker MYSZ, with the company headquartered in Israel but using a United States listing to access U.S. capital markets, and it continues to trade as an actively listed micro-cap without any confirmed delisting or completed take-private transaction reported by Nasdaq or the SEC in 2025 or 2026.

The most recent substantial corporate communication was a merger-related announcement in March 2026 in which My Size described its progress on integrating Orgad's operations and reiterated that the combination aims to leverage Orgad's e-commerce infrastructure alongside My Size's sizing technology, based on company investor materials and prior press releases posted on the investor relations website.

While the share price on 05/29/2026 showed no outsized swing compared with earlier May sessions, the U.S. listing on Nasdaq remains the central reference point for My Size's equity valuation, and the absence of fresh hard news on the tape leaves short-term trading dynamics largely driven by broader micro-cap sentiment and liquidity conditions in the United States.

German investors can also access My Size through secondary trading lines such as Tradegate, where pricing is derived from the underlying U.S. quote and translated into euro terms, although liquidity on these German venues typically remains well below Nasdaq volumes and bid-ask spreads tend to be wider for this micro-cap stock.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

My Size Inc: core business model

My Size focuses on digital sizing and fit technology for retailers and brands, generating revenue primarily from software subscriptions and e-commerce services that help merchants reduce returns and improve conversion in online and omnichannel sales.

Valuation metrics and multiples for My Size Inc

Given its small market capitalization and limited analyst coverage, My Size does not feature prominently in mainstream valuation screens, and widely followed metrics such as forward price-to-earnings or EV/EBITDA ratios are often not meaningful because the company has yet to establish consistent profitability on a U.S. GAAP basis according to its recent annual and quarterly filings.

Market data providers that track micro-cap stocks indicate that the valuation narrative around My Size is more closely tied to revenue growth potential from its sizing technology and e-commerce operations than to traditional dividend or earnings-based measures, as the company has not declared regular dividends and continues to reinvest in product development and customer acquisition according to its latest available financial statements.

Conclusion

With no fresh regulatory filings or press releases on 05/29/2026, My Size's Nasdaq-listed shares traded without a strong directional impulse, reflecting the absence of new price-relevant catalysts in the United States market session.

Valuation for the micro-cap remains tied more to expectations for scaling its sizing technology and Orgad-related e-commerce activities than to conventional earnings-based metrics, which are still constrained by the lack of sustained profitability, leaving investors to watch upcoming quarters for clearer signals on growth and margin progress.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.